Health care stocks fell late Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both shedding 0.7%.
The iShares Biotechnology ETF (IBB) rose 0.3%.
In corporate news, Nuwellis (NUWE) shares almost doubled after the Centers for Medicare and Medicaid Services almost quintupled the reimbursement rate for the company's Aduadex SmartFlow therapy, effective Jan. 1.
KalVista Pharmaceuticals (KALV) shares jumped 11%. The company closed a royalty financing deal with DRI Healthcare Trust for up to $179 million.
BioNTech (BNTX) expects full-year revenue at the low end of guidance due in part to inventory writedowns, even as variant-adapted COVID-19 vaccines helped boost Q3 results. The shares fell 1.7%.
PACS (PACS) shares tumbled 32% following a report by short-seller Hindenburg Research.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。